DBVT
DBV Technologies
NASDAQ: DBVT · HEALTHCARE · BIOTECHNOLOGY
$21.00
+3.45% today
Updated 2026-04-30
Market cap
$1.17B
P/E ratio
—
P/S ratio
207.92x
EPS (TTM)
$-5.25
Dividend yield
—
52W range
$8 – $26
Volume
0.2M
DBV Technologies (DBVT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130480.00 | $209057.00 | $236363.00 | $163373.00 | $230592.00 | $251318.00 | $256578.00 | $220847.00 | $7.93M | $11.52M | $12.81M | $14.71M | $11.28M | $5.71M | $4.80M | $15.73M | $2.57M | $0.00 |
| Revenue growth (YoY) | — | +60.2% | +13.1% | -30.9% | +41.1% | +9.0% | +2.1% | -13.9% | +3489.4% | +45.3% | +11.3% | +14.8% | -23.3% | -49.4% | -15.9% | +227.7% | -83.7% | -100.0% |
| Cost of revenue | $243346.00 | $349690.00 | $320364.00 | $238869.00 | $109712.00 | $140848.00 | $165377.00 | $139942.00 | $1.42M | $3.43M | $5.03M | $3.09M | $17.49M | $9.27M | $20.30M | $-4.50M | $6.81M | $17.67M |
| Gross profit | $-113000.00 | $-141000.00 | $-84000.00 | $-63567.00 | $120879.00 | $110469.00 | $91200.00 | $80904.00 | $7.93M | $11.52M | $12.81M | $14.71M | $11.28M | $-3.56M | $-15.50M | $15.73M | $-6.81M | $-17.67M |
| Gross margin | -86.6% | -67.4% | -35.5% | -38.9% | 52.4% | 44.0% | 35.5% | 36.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -62.5% | -322.9% | 100.0% | -265.3% | — |
| R&D | $4.48M | $4.56M | $6.49M | $8.65M | $15.21M | $23.98M | $27.43M | $36.85M | $82.90M | $126.25M | $123.50M | $112.24M | $101.61M | $70.34M | $75.50M | $60.22M | $89.90M | $22.78M |
| SG&A | — | — | — | $4.05M | $6.08M | $8.71M | $9.72M | $18.35M | $36.62M | $42.49M | $45.39M | $49.17M | $35.08M | $30.52M | $17.56M | $29.50M | $28.74M | $15.98M |
| Operating income | $-7.51M | $-6.34M | $-8.17M | $-9.41M | $-17.67M | $-27.48M | $-29.82M | $-54.34M | $-122.13M | $-173.94M | $-190.12M | $-171.02M | $-158.84M | $-98.61M | $-96.63M | $-76.43M | $-120.53M | $-153.16M |
| Operating margin | -5753.4% | -3033.1% | -3457.0% | -5760.4% | -7664.2% | -10932.8% | -11622.2% | -24603.5% | -1540.6% | -1510.0% | -1483.6% | -1162.8% | -1408.7% | -1727.6% | -2013.1% | -486.0% | -4693.4% | — |
| EBITDA | $-5.82M | $-4.75M | $-6.10M | $-9.11M | $-16.67M | $-29.56M | $-28.45M | $-47.51M | $-126.29M | $-176.90M | $-206.16M | $-168.43M | $-124.83M | $-91.16M | $-76.68M | $-63.27M | $-110.99M | $-135.49M |
| EBITDA margin | -4463.5% | -2273.1% | -2579.9% | -5575.6% | -7229.7% | -11760.4% | -11086.7% | -21512.2% | -1593.1% | -1535.7% | -1608.7% | -1145.1% | -1107.0% | -1597.0% | -1597.5% | -402.3% | -4321.9% | — |
| EBIT | $-6.02M | $-4.94M | $-6.31M | $-9.33M | $-17.04M | $-30.03M | $-29.26M | $-48.79M | $-127.78M | $-180.20M | $-209.40M | $-171.02M | $-135.29M | $-99.53M | $-96.98M | $-76.43M | $-117.80M | $-153.16M |
| Interest expense | $48178.00 | $42784.00 | $48819.00 | $55212.00 | $33337.00 | $33140.00 | $125249.00 | $159622.00 | $17650.00 | $3.99M | $479764.00 | $377929.00 | $724000.00 | $690000.00 | $427000.00 | — | $740000.00 | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.07M | $-4.98M | $-6.36M | $-9.38M | $-17.02M | $-26.59M | $-29.07M | $-48.52M | $-126.35M | $-177.20M | $-190.26M | $-172.01M | $-159.56M | $-97.81M | $-96.30M | $-72.73M | $-113.72M | $-147.40M |
| Net income growth (YoY) | — | +17.9% | -27.6% | -47.6% | -81.4% | -56.2% | -9.3% | -66.9% | -160.4% | -40.2% | -7.4% | +9.6% | +7.2% | +38.7% | +1.5% | +24.5% | -56.4% | -29.6% |
| Profit margin | -4651.3% | -2382.6% | -2689.5% | -5744.5% | -7382.7% | -10579.0% | -11327.9% | -21969.5% | -1593.9% | -1538.3% | -1484.7% | -1169.5% | -1415.0% | -1713.5% | -2006.3% | -462.4% | -4428.2% | — |